Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Coronary CTA Use in Emergency Department saves time and money

Reference: Goldstein JA, Chinnaiyan KM, Abidov A, et al. The CT-STAT (coronary computed tomographic angiography for systemic triage of acute chest pain patients to treatment) trial. J Am Coll Cardiol 2011; 58: 1414-22.

Using coronary computed tomographic angiography (CTA) as a screening tool for low-risk patients with chest pain in the emergency department achieves lower costs and faster diagnoses compared with myocardial perfusion imaging but does not sacrifice safety or accuracy, according to results of a randomized trial appearing in the September 27, 2011, issue of the Journal of the American College of Cardiology.

For the trial, researchers led by Gilbert L. Raff, MD, of William Beaumont Hospital (Royal Oak, MI), randomized 699 patients with low-risk acute chest pain (TIMI risk score ≤ 4; normal initial ECG and cardiac enzymes) to standard nuclear stress imaging or coronary CTA as an initial screen at 16 different emergency departments between June 2007 and November 2008.

Both groups had substantial portions of patients ruled out from having significant CAD (82.2% with CTA, 89.9% with nuclear stress imaging). In addition, 24 patients (6.7%) were referred for invasive coronary angiography after CTA, with 13 (3.6%) receiving subsequent revascularization (4 CABG, 9 PCI). After nuclear stress imaging, 21 patients (6.2%) went on to coronary angiography (P = 0.8 compared with CTA), with 8 (2.4%) subsequently receiving revascularization (8 PCI, 0 CABG; P = 0.34 compared with CTA with regard to total revascularizations). There were no CABG procedures in the stress imaging arm.

SOLACI.ORG

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

HERA-TAVI: Intra-Annular vs Supra-Annular Valves in TAVI

The HERA-TAVI study is an international multicenter registry that compared the clinical and hemodynamic outcomes of contemporary self-expanding transcatheter heart valves with intra-annular (IA)...

DOUBLE-CHOICE: Lower Pacemaker Implantation Rates with ACURATE neo2 Compared with Evolut in Patients Undergoing TAVI

The DOUBLE-CHOICE trial is a multicenter, randomized, controlled study conducted in Germany to evaluate the performance of next-generation transcatheter heart valves and different anesthesia...